相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular mechanism of hepatitis C virus replicon variants with reduced susceptibility to a benzofuran inhibitor, HCV-796
Anita Y. M. Howe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
The hepatitis C virus replicon presents a higher barrier to resistance to nucleoside analogs than to nonnucleoside polymerase or protease inhibitors
Matthew F. McCown et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Naturally Occurring Dominant Resistance Mutations to Hepatitis C Virus Protease and Polymerase Inhibitors in Treatment-Naive Patients
Thomas Kuntzen et al.
HEPATOLOGY (2008)
Existence of hepatitis C virus NS5B variants naturally resistant to non-nucleoside, but not to nucleoside, polymerase inhibitors among untreated patients
Sophie Le Pogam et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Activity of a potent hepatitis C virus polymerase inhibitor in the chimpanzee model
Chih-Ming Chen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
General catalytic deficiency of hepatitis C virus RNA polymerase with an S282T mutation and mutually exclusive resistance towards 2′-modified nucleotide analogues
Helene Dutartre et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Competitive fitness of nevirapine-resistant human immunodeficiency virus type 1 mutants
JA Collins et al.
JOURNAL OF VIROLOGY (2004)
Prevalence of and risk factors for viral infections among human immunodeficiency virus (HIV) - Infected and high-risk HIV-uninfected women
CT Stover et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
分享论文
